1017 related articles for article (PubMed ID: 2538506)
1. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
Sherris D; Stohl W; Mayer L
J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
[TBL] [Abstract][Full Text] [Related]
2. T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3.
Hirohata S; Jelinek DF; Lipsky PE
J Immunol; 1988 Jun; 140(11):3736-44. PubMed ID: 2967324
[TBL] [Abstract][Full Text] [Related]
3. Frequency of human B cells that differentiate in response to anti-CD3-activated T cells.
Amoroso K; Lipsky PE
J Immunol; 1990 Nov; 145(10):3155-61. PubMed ID: 2146316
[TBL] [Abstract][Full Text] [Related]
4. Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells.
Vernino L; McAnally LM; Ramberg J; Lipsky PE
J Immunol; 1992 Jan; 148(2):404-10. PubMed ID: 1530861
[TBL] [Abstract][Full Text] [Related]
5. Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes.
van Lier RA; Brouwer M; Rebel VI; van Noesel CJ; Aarden LA
Immunology; 1989 Sep; 68(1):45-50. PubMed ID: 2530156
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
7. Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation.
Nakagawa T; Nakagawa N; Goldstein H; Volkman DJ; Fauci AS
J Immunol; 1986 Nov; 137(10):3175-82. PubMed ID: 2945860
[TBL] [Abstract][Full Text] [Related]
8. Human helper T cell factor(s). III. Characterization of B cell differentiation factor I (BCDF I).
Hirano T; Teranishi T; Onoue K
J Immunol; 1984 Jan; 132(1):229-34. PubMed ID: 6228579
[TBL] [Abstract][Full Text] [Related]
9. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
Tohma S; Hirohata S; Lipsky PE
J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
[TBL] [Abstract][Full Text] [Related]
10. Growth factor production and requirements during the proliferative response of human T lymphocytes to anti-CD3 monoclonal antibody.
Granelli-Piperno A; Keane M; Steinman RM
J Immunol; 1989 Jun; 142(12):4138-43. PubMed ID: 2524526
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells.
Tohma S; Lipsky PE
J Immunol; 1991 Apr; 146(8):2544-52. PubMed ID: 1707911
[TBL] [Abstract][Full Text] [Related]
12. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.
Noelle RJ; McCann J; Marshall L; Bartlett WC
J Immunol; 1989 Sep; 143(6):1807-14. PubMed ID: 2476483
[TBL] [Abstract][Full Text] [Related]
13. T cell regulation of human B cell proliferation and differentiation. Regulatory influences of CD45R+ and CD45R- T4 cell subsets.
Hirohata S; Lipsky PE
J Immunol; 1989 Apr; 142(8):2597-607. PubMed ID: 2564858
[TBL] [Abstract][Full Text] [Related]
14. Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals.
Landis RC; Friedman ML; Fisher RI; Ellis TM
J Immunol; 1991 Jan; 146(1):128-35. PubMed ID: 1824588
[TBL] [Abstract][Full Text] [Related]
15. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
16. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
Shimizu K; Hirano T; Ishibashi K; Nakano N; Taga T; Sugamura K; Yamamura Y; Kishimoto T
J Immunol; 1985 Mar; 134(3):1728-33. PubMed ID: 2981920
[TBL] [Abstract][Full Text] [Related]
17. Distinct regulatory effects of IL-4 and TNF-alpha during CD3-dependent and CD3-independent initiation of human T-cell activation.
Damle NK; Doyle LV
Lymphokine Res; 1989; 8(2):85-97. PubMed ID: 2525210
[TBL] [Abstract][Full Text] [Related]
18. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
19. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
[TBL] [Abstract][Full Text] [Related]
20. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
